ENTX Long Call Strategy
ENTX (Entera Bio Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
ENTX (Entera Bio Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $63.5M, a beta of 1.55 versus the broader market, a 52-week range of 0.91-3.22, average daily share volume of 174K, a public-listing history dating back to 2018, approximately 18 full-time employees. These structural characteristics shape how ENTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.55 indicates ENTX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on ENTX?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current ENTX snapshot
As of May 15, 2026, spot at $1.25, ATM IV 23.50%, IV rank 1.22%, expected move 6.74%. The long call on ENTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on ENTX specifically: ENTX IV at 23.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a ENTX long call, with a market-implied 1-standard-deviation move of approximately 6.74% (roughly $0.08 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ENTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on ENTX should anchor to the underlying notional of $1.25 per share and to the trader's directional view on ENTX stock.
ENTX long call setup
The ENTX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ENTX near $1.25, the first option leg uses a $1.25 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ENTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ENTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.25 | N/A |
ENTX long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ENTX long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ENTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ENTX
Long calls on ENTX express a bullish thesis with defined risk; traders use them ahead of ENTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ENTX thesis for this long call
The market-implied 1-standard-deviation range for ENTX extends from approximately $1.17 on the downside to $1.33 on the upside. A ENTX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ENTX IV rank near 1.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ENTX at 23.50%. As a Healthcare name, ENTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ENTX-specific events.
ENTX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ENTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ENTX alongside the broader basket even when ENTX-specific fundamentals are unchanged. Long-premium structures like a long call on ENTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ENTX chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ENTX?
- A long call on ENTX is the long call strategy applied to ENTX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ENTX stock trading near $1.25, the strikes shown on this page are snapped to the nearest listed ENTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ENTX long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ENTX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 23.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ENTX long call?
- The breakeven for the ENTX long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ENTX market-implied 1-standard-deviation expected move is approximately 6.74%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ENTX?
- Long calls on ENTX express a bullish thesis with defined risk; traders use them ahead of ENTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ENTX implied volatility affect this long call?
- ENTX ATM IV is at 23.50% with IV rank near 1.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.